½ÃÀ庸°í¼­
»óǰÄÚµå
1636005

´ëÀå³»½Ã°æ °Ë»ç ±â±â ½ÃÀå º¸°í¼­ : Á¦Ç° À¯Çüº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°(2025-2033³â)

Colonoscopy Devices Market Report by Product Type, Application, End User, and Region 2025-2033

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: IMARC | ÆäÀÌÁö Á¤º¸: ¿µ¹® 122 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

´ëÀå³»½Ã°æ °Ë»ç ±â±â ½ÃÀåÀÇ ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â 17¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº 2033³â±îÁö ½ÃÀå ±Ô¸ð°¡ 25¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óÇϸç, 2025³âºÎÅÍ 2033³â±îÁö 4.5% ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» ±â·ÏÇÒ °ÍÀ¸·Î Àü¸ÁÇϰí ÀÖ½À´Ï´Ù. ÀåºñÀÇ ±â¼ú ¹ßÀü, ¿¹¹æ ÀÇ·á¿¡ ´ëÇÑ Àνİú Á߿伺 Áõ°¡, Á¤ºÎÀÇ ´ëÀå¾Ï °ËÁø Á¤Ã¥, ºñ¿ë È¿À²ÀûÀÎ Àåºñ °³¹ß, ÀÇ·áºñ Áõ°¡, 1ÀÎ´ç ¼Òµæ Áõ°¡, ÀÇ·á º¸Çè Àû¿ë ¹üÀ§ È®´ë µîÀÌ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

´ëÀå³»½Ã°æ °Ë»ç±â±â ½ÃÀå µ¿Çâ:

´ëÀå¾Ï À¯º´·ü Áõ°¡

°øÁߺ¸°ÇÀÇ Áß´ëÇÑ °ü½É»çÀÎ ´ëÀå¾ÏÀº Àü ¼¼°èÀûÀ¸·Î ¹ßº´·üÀÌ ²ÙÁØÈ÷ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Áõ°¡´Â Àα¸ °í·ÉÈ­, »ýȰ½À°üÀÇ º¯È­, À¯ÀüÀû ¼ÒÀÎ µîÀÇ ¿äÀο¡ ±âÀÎÇÕ´Ï´Ù. ÀÌ¿¡ µû¶ó Á¶±â ¹ß°ß ¹× °ËÁø¿¡ ´ëÇÑ Çʿ伺ÀÌ ³ô¾ÆÁö°í ÀÖÀ¸¸ç, ´ëÀå³»½Ã°æ °Ë»ç°¡ ÇʼöÀûÀ¸·Î ¿ä±¸µÇ°í ÀÖ½À´Ï´Ù. ´ëÀå³»½Ã°æ °Ë»ç´Â ´ëÀå¾Ï °ËÁøÀÇ °¡Àå È¿°úÀûÀÎ ¹æ¹ýÀ̸ç, Á¶±â Áø´Ü¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϸç ȯÀÚÀÇ ¿¹ÈÄ¿¡ Á÷Á¢ÀûÀÎ ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ÀÇ·á ½Ã½ºÅÛÀº ¾Ï °ü·Ã ÀÌȯÀ²°ú »ç¸Á·üÀ» ³·Ãß±â À§ÇØ ¿¹¹æ ÀÇ·á¿Í Á¶±â °³ÀÔÀ» °­Á¶Çϰí ÀÖÀ¸¸ç, Àü ¼¼°è ´ëÀå¾Ï ȯÀÚÀÇ ±ÞÁõÀº ´ëÀå³»½Ã°æ °Ë»ç ±â±â ¼ö¿äÀÇ ÁÖ¿ä ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù.

´ëÀå³»½Ã°æ °Ë»ç ±â±âÀÇ ±â¼úÀû Áøº¸

´ëÀå³»½Ã°æ °Ë»ç ±â±â ºÐ¾ß¿¡¼­´Â »ó´çÇÑ ±â¼ú ¹ßÀüÀÌ ÀÌ·ç¾îÁ® Áø´ÜÀÇ Á¤È®¼º°ú ȯÀÚÀÇ ÆíÀǼºÀÌ Å©°Ô Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ÃֽŠÀåºñ´Â °íÈ­Áú ¿µ»ó°ú °­È­µÈ ±¤ÇÐ ½Ã½ºÅÛÀ» ÅëÇØ ´ëÀåÀ» º¸´Ù ¼±¸íÇÏ°í ¼¼¹ÐÇÏ°Ô º¼ ¼ö ÀÖ¾î ¿ëÁ¾°ú °°Àº ÀÌ»óÀ» ¹ß°ßÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ĸ½¶ ´ëÀå³»½Ã°æÀ̳ª °¡»ó ´ëÀå³»½Ã°æ°ú °°Àº Çõ½ÅÀûÀÎ °Ë»ç´Â ÷´Ü ¿µ»ó ±â¼úÀ» Ȱ¿ëÇÏ¿© ±âÁ¸ °Ë»ç¿¡ ´ëÇÑ ºñħ½ÀÀû ´ë¾ÈÀ» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ÁøÁ¤ ±â¼ú ¹× ÅëÁõ °ü¸® ±â¼úÀÇ ¹ß´Þ·Î ȯÀڵ鿡°Ô º¸´Ù Æí¾ÈÇÑ °Ë»ç¸¦ Á¦°øÇÔÀ¸·Î½á °ËÁø ¼ö¿ëµµ ¹× °ËÁø ±Ç°í ÁؼöÀ²À» ³ôÀ̰í ÀÖ½À´Ï´Ù.

°í·ÉÈ­ ÁøÇà

°í·ÉÈ­´Â ´ëÀå³»½Ã°æ ±â±â ½ÃÀåÀÇ Áß¿äÇÑ ÃËÁø¿äÀÎÀÔ´Ï´Ù. °í·ÉÀÚ´Â ´ëÀå¾ÏÀ» Æ÷ÇÔÇÑ ¼ÒÈ­±â ÁúȯÀÇ ¹ßº´ À§ÇèÀÌ ³ô½À´Ï´Ù. Àü ¼¼°è Àα¸°¡ °í·ÉÈ­µÊ¿¡ µû¶ó ƯÈ÷ ¼±Áø±¹¿¡¼­ ´ëÀå³»½Ã°æ °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àα¸Åë°èÇÐÀû º¯È­´Â Æò±Õ ¼ö¸íÀÇ ¿¬Àå°ú º£À̺ñºÕ ¼¼´ë¿Í °°Àº ´ë±Ô¸ð Àα¸ ÄÚȣƮÀÇ °í·ÉÈ­¿¡ ±âÀÎÇÕ´Ï´Ù. ¿¬·ÉÀÌ ´ëÀå¾ÏÀÇ Áß¿äÇÑ À§Çè¿äÀÎÀ̱⠶§¹®¿¡ Á¶±â ¹ß°ß°ú Ä¡·á¸¦ À§Çؼ­´Â ´ëÀå³»½Ã°æ °Ë»ç¸¦ ÅëÇÑ Á¤±âÀûÀÎ °ËÁøÀÌ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ¿¡ µû¶ó Àü ¼¼°è ³ëÀÎ Àα¸ÀÇ Áõ°¡·Î ÀÎÇØ ´ëÀå³»½Ã°æ °Ë»ç ¼­ºñ½º ¹× ÀåºñÀÇ Áõ°¡°¡ ÇÊ¿äÇϸç, ÀÌ´Â ½ÃÀå È®´ëÀÇ Áß¿äÇÑ ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

¿¹¹æÀÇ·á¿¡ ´ëÇÑ ÀÎ½Ä Á¦°í¿Í Á߿伺

ÃÖ±Ù Áúº´ Á¶±â ¹ß°ßÀÇ Á߿伺¿¡ ´ëÇÑ ÀϹÝÀεéÀÇ Àνİú ±³À°ÀÌ ³ô¾ÆÁö¸é¼­ ¿¹¹æÀÇÇÐÀ¸·ÎÀÇ ÀüȯÀÌ µÎµå·¯Áö°Ô ³ªÅ¸³ª°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¯È­´Â Á¤±âÀûÀÎ °ËÁøÀ» ÅëÇØ »ç¸Á·üÀ» Å©°Ô ³·Ãâ ¼ö ÀÖ´Â ´ëÀå¾Ï¿¡¼­ ƯÈ÷ µÎµå·¯Áö°Ô ³ªÅ¸³ª°í ÀÖ½À´Ï´Ù. °øÁߺ¸°Ç Ä·ÆäÀÎ, ÀÇ·á ¼­ºñ½º Á¦°øÀÚÀÇ ±³À°Àû ³ë·Â, Á¤ºÎ ÇÁ·Î±×·¥Àº Á¤±âÀûÀÎ ´ëÀå³»½Ã°æ °ËÁøÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀνÄÀ» ³ôÀÌ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇØ¿Ô½À´Ï´Ù. ÀÌ·¯ÇÑ ÀνÄÀÇ Áõ°¡´Â ¿¹¹æÀû ´ëÀå³»½Ã°æ °Ë»ç¸¦ ¹Þ´Â Àα¸ÀÇ Áõ°¡·Î À̾îÁ® ´ëÀå³»½Ã°æ °Ë»ç ±â±â¿¡ ´ëÇÑ ¼ö¿ä¸¦ °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ¿¹¹æ ÀÇ·áÀÇ Á߿伺Àº ´ëÀå ÁúȯÀ» Á¶±â¿¡ ¹ß°ßÇÏ´Â µ¥ µµ¿òÀÌ µÉ »Ó¸¸ ¾Æ´Ï¶ó, ÁøÇ༺ Áúȯ¿¡ ´ëÇÑ ´ë±Ô¸ð Ä¡·áÀÇ Çʿ伺À» ÇÇÇÔÀ¸·Î½á Àå±âÀûÀ¸·Î ÀÇ·áºñ Àý°¨¿¡µµ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • Á¶»ç ¸ñÀû
  • ÀÌÇØ°ü°èÀÚ
  • µ¥ÀÌÅÍ ¼Ò½º
    • 1Â÷ Á¤º¸
    • 2Â÷ Á¤º¸
  • ½ÃÀå ÃßÁ¤
    • »óÇâ½Ä Á¢±Ù
    • ÇÏÇâ½Ä Á¢±Ù
  • Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼Ò°³

  • °³¿ä
  • ÁÖ¿ä ¾÷°è µ¿Çâ

Á¦5Àå ¼¼°èÀÇ ´ëÀå³»½Ã°æ °Ë»ç ±â±â ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå ½ÇÀû
  • COVID-19ÀÇ ¿µÇâ
  • ½ÃÀå ¿¹Ãø

Á¦6Àå ½ÃÀå ³»¿ª : Á¦Ç° À¯Çüº°

  • ´ëÀå³»½Ã°æ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • °¡½ÃÈ­ ½Ã½ºÅÛ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ±âŸ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦7Àå ½ÃÀå ³»¿ª : ¿ëµµº°

  • ´ëÀå¾Ï
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ¸°Ä¡ÁõÈıº
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ±Ë¾ç¼º ´ëÀå¿°
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • Å©·Ðº´
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ±âŸ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦8Àå ½ÃÀå ³»¿ª : ÃÖÁ¾»ç¿ëÀÚº°

  • º´¿ø
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ±âŸ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦9Àå ½ÃÀå ³»¿ª : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • Àεµ³×½Ã¾Æ
    • ±âŸ
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ·¯½Ã¾Æ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦10Àå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ

  • °³¿ä
  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ±âȸ

Á¦11Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦12Àå Porter's Five Forces ºÐ¼®

  • °³¿ä
  • ±¸¸ÅÀÚÀÇ ±³¼··Â
  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • °æÀï Á¤µµ
  • ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
  • ´ëüǰÀÇ À§Çù

Á¦13Àå °¡°Ý ºÐ¼®

Á¦14Àå °æÀï ±¸µµ

  • ½ÃÀå ±¸Á¶
  • ÁÖ¿ä ±â¾÷
  • ÁÖ¿ä ±â¾÷ °³¿ä
    • Endomed Systems GmbH
    • FUJIFILM Holdings Corporation
    • GI-View Ltd.
    • HOYA Corporation
    • KARL STORZ SE & Co. KG
    • Medtronic plc
    • Olympus Corporation
    • STERIS Corporation
ksm 25.02.19

The global colonoscopy devices market size reached USD 1.70 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.52 Billion by 2033, exhibiting a growth rate (CAGR) of 4.5% during 2025-2033. The technological advancements in devices, increased awareness and emphasis on preventive healthcare, governmental colorectal cancer screening initiatives, development of cost-effective devices, rising healthcare expenditure, burgeoning per capita income, and expanding healthcare insurance coverage are some of the factors stimulating the market growth.

Colonoscopy Devices Market Trends:

Rising prevalence of colorectal cancer

Colorectal cancer, a significant public health concern, has been witnessing a steady increase in incidence worldwide. This uptick is attributed to factors such as aging populations, lifestyle changes, and genetic predispositions. As a result, there is a heightened need for early detection and screening, making colonoscopy procedures essential. Colonoscopy, being the most effective method for colorectal cancer screening, plays a crucial role in early diagnosis, directly impacting patient outcomes. The surge in colorectal cancer cases globally is a primary driver for the demand for colonoscopy devices, as healthcare systems emphasize preventive care and early intervention to reduce cancer-related morbidity and mortality.

Technological advancements in colonoscopy devices

The field of colonoscopy devices has seen significant technological advancements, substantially improving diagnostic accuracy and patient comfort. Modern devices feature high-definition imaging and enhanced optical systems, offering clearer and more detailed visualizations of the colon, which is pivotal for detecting abnormalities like polyps. Innovations such as capsule colonoscopy and virtual colonoscopy utilize advanced imaging techniques, providing non-invasive alternatives to traditional methods. Furthermore, developments in sedation techniques and pain management have made the procedure more comfortable for patients, leading to increased acceptance and compliance with screening recommendations.

Escalating aging population

An aging population is a significant driver of the colonoscopy devices market. Older individuals are at a higher risk of developing gastrointestinal diseases, including colorectal cancer. As the global population ages, particularly in developed countries, there is an increasing demand for colonoscopy procedures. This demographic shift is due to longer life expectancies and the aging of large population cohorts, such as the baby boomer generation. With age being a critical risk factor for colorectal cancer, regular screenings via colonoscopy become vital for early detection and treatment. Consequently, the growing number of elderly individuals globally necessitates a corresponding increase in colonoscopy services and devices, making it a key factor in the market's expansion.

Growing awareness and emphasis on preventive healthcare

In recent years, there has been a significant shift towards preventive healthcare, with increased public awareness and education about the importance of early detection of diseases. This shift is particularly evident in the context of colorectal cancer, where regular screenings can significantly reduce mortality rates. Public health campaigns, educational initiatives by healthcare providers, and government programs have played a pivotal role in raising awareness about the benefits of regular colonoscopy screenings. This heightened awareness has led to an increase in the number of individuals undergoing preventive colonoscopies, thereby driving the demand for colonoscopy devices. The emphasis on preventive healthcare not only helps in the early detection of colorectal conditions but also aids in reducing healthcare costs in the long run by avoiding the need for extensive treatments for advanced diseases.

Colonoscopy Devices Industry Segmentation:

Breakup by Product Type:

Colonoscope

Visualization Systems

Others

Colonoscope accounts for the majority of the market share

Breakup by Application:

Colorectal Cancer

Lynch Syndrome

Ulcerative Colitis

Crohn's Disease

Others

Colorectal cancer accounts for the majority of the market share

Breakup by End User:

Hospitals

Ambulatory Surgery Center

Others

Hospitals accounts for the majority of the market share

Breakup by Region:

North America

United States

Canada

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest colonoscopy devices market share

North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Endomed Systems GmbH

FUJIFILM Holdings Corporation

GI-View Ltd.

HOYA Corporation

KARL STORZ SE & Co. KG

Medtronic plc

Olympus Corporation

STERIS Corporation

Key Questions Answered in This Report

  • 1. How big is the global colonoscopy devices market?
  • 2. What is the expected growth rate of the global colonoscopy devices market during 2025-2033?
  • 3. What are the key factors driving the global colonoscopy devices market?
  • 4. What has been the impact of COVID-19 on the global colonoscopy devices market?
  • 5. What is the breakup of the global colonoscopy devices market based on the product type?
  • 6. What is the breakup of the global colonoscopy devices market based on the application?
  • 7. What is the breakup of the global colonoscopy devices market based on the end user?
  • 8. What are the key regions in the global colonoscopy devices market?
  • 9. Who are the key players/companies in the global colonoscopy devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Colonoscopy Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Colonoscope
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Visualization Systems
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Colorectal Cancer
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Lynch Syndrome
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Ulcerative Colitis
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Crohn's Disease
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgery Center
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Endomed Systems GmbH
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 FUJIFILM Holdings Corporation
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 GI-View Ltd.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 HOYA Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 KARL STORZ SE & Co. KG
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 SWOT Analysis
    • 14.3.6 Medtronic plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Olympus Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 STERIS Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦